Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in the delivery of psychedelic therapies, today announced that Ronan Levy, Chairman & Chief Executive Officer of Field Trip Health & Wellness, will webcast live at the KCSA Mental Health Conference, hosted by VirtualInvestorConferences.com, on Thursday, December 15th, 2022.
A recording of the webcast presentation will be available on the Events and Presentations section of Field Trip’s investor relations website following the events.
The Field Trip management team will also participate in one-on-one investor meetings following the conference. For institutional investors to schedule a meeting, please contact fieldtripIR@kcsa.com.
Recent Company Highlights
- Provided a business update and reported fiscal second quarter 2023 results.
- Launched Freedom by Field Trip™, a first-of-its-kind one-year hybrid ketamine therapy program that blends the power of psychedelic-assisted therapies with holistic wellness support.
- Announced the relaunch and refresh of its award-winning psychedelic app, now named Field Trip.
- Strengthened leadership team with two executive appointments.
About Field Trip Health & Wellness Ltd
With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.